← Open Payments lookup

SAMANTHA DELAHANTY: Open Payments

NPI 1124750492 · LOWELL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,087 in 197 payments from 19 companies in 2025. Trend: 2023 $56 · 2024 $1,576 · 2025 $4,087

Food & beverage: $4,010Education: $77
CompanyPaymentsAmount
ABBVIE INC.36$652
Janssen Biotech, Inc.22$562
Takeda Pharmaceuticals U.S.A., Inc.25$513
Salix Pharmaceuticals, a division of Bausch Health US, LLC35$416
Gilead Sciences, Inc.15$397
Ardelyx, Inc.13$283
PFIZER INC.13$234
Phathom Pharmaceuticals, Inc.8$183
Madrigal Pharmaceuticals4$157
Ipsen Biopharmaceuticals, Inc5$130

Products named: TREMFYA, ENTYVIO, XIFAXAN, IBSRELA, RINVOQ, DUPIXENT, VOQUEZNA, XELJANZ.

Industry payments across MA — which companies pay providers there.